Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. PRE
PRE logo

PRE Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Prenetics Global Ltd (PRE) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
19.940
1 Day change
-2.68%
52 Week Range
22.860
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Prenetics Global Ltd (PRE) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong revenue growth, insider confidence, and recent share buyback plan suggest significant long-term potential. Despite some technical indicators showing neutral or slightly bearish trends, the overall sentiment and fundamentals support a buy decision.

Technical Analysis

The MACD histogram is negative (-0.521) but contracting, suggesting a potential reversal. RSI is neutral at 27.773, and moving averages are converging, indicating no strong trend. Key support is at 14.864, and resistance is at 18.463. The stock is trading near resistance levels, but pre-market momentum (+10.02%) indicates bullish sentiment.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

The low open interest put-call ratio (0.07) suggests bullish sentiment, while the high option volume put-call ratio (2.12) indicates short-term bearish activity. Implied volatility is high (134.82), reflecting elevated uncertainty.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
8

Positive Catalysts

  • $40 million share buyback plan to address stock undervaluation.

  • Insider confidence with $1.3 million stock purchases, including $750,000 by the CEO.

  • Revenue guidance for IM8 brand at $180-$200 million for 2026, showcasing strong growth potential.

  • Significant YoY revenue growth of 248.57% in Q4 2025.

Neutral/Negative Catalysts

  • Net income remains negative at -$28.12 million, though improving YoY.

  • EPS is still negative (-1.75), which may deter some investors.

  • Neutral sentiment from hedge funds and insiders over the last quarter.

Financial Performance

In Q4 2025, revenue increased by 248.57% YoY to $36.56 million. Net income improved by 72.05% YoY but remains negative at -$28.12 million. EPS increased by 36.72% YoY to -1.75, and gross margin improved significantly by 34.49% to 59.47%. These figures indicate strong growth trends despite ongoing losses.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Roth Capital initiated coverage with a Buy rating and a $36 price target, citing IM8's rapid scaling to over $100 million in revenue and its underappreciated growth potential at current share levels.

Wall Street analysts forecast PRE stock price to rise
Analyst Rating
0
Wall Street analysts forecast PRE stock price to rise
Buy
Hold
Sell
0
Current: 20.490
sliders
Low
0
Averages
0
High
0
0
Current: 20.490
sliders
Low
0
Averages
0
High
0
Roth Capital
George Kelly
Buy
initiated
$36
AI Analysis
2026-02-11
Reason
Roth Capital
George Kelly
Price Target
$36
AI Analysis
2026-02-11
initiated
Buy
Reason
Roth Capital analyst George Kelly initiated coverage of Prenetics with a Buy rating and $36 price target. The company has "struggled to find its footing" after completing its business combination with SPAC Artisan Acquisition but has "found a winner" in complement brand IM8," the analyst tells investors in a research note. The firm says IM8 has quickly scaled to over $100M in revenue and has now become management's sole focus. Roth says IM8's growth potential is underappreciated at current share levels.

People Also Watch